SHIFT Newsroom · UK
TRANSFORM: better representation in UK prostate screening research
UK archive · Original report: 4 June 2026. Additional funding announced in June 2026 aims to widen Black men’s participation. Expansion is staged, with invitations rather than self-referral.
UK archive review · 13 September 2026. Original source: 4 June 2026. This article revisits a UK development; it is not a new announcement today.
What the funding is intended to do
The NIHR announced up to £18 million in additional funding for the TRANSFORM prostate-screening trial. The aim is to improve representation of Black men while comparing promising screening approaches.
The announcement describes staged expansion. Inviting all eligible Black men aged 45–74 into Stage 2 depends on Stage 1 succeeding. Funding approval is therefore not evidence that every eligible person has already received an invitation.
The route into the trial
Invitations are sent through GP practices. The NIHR explicitly says men cannot volunteer directly for TRANSFORM. This is different from an open sign-up research registry and from Prostate Progress, which concerns men with current or previous prostate cancer.
A screening trial also does not establish that the tested approach should already become routine national screening. Its purpose is to examine benefits and potential harms before such decisions are made.
What an invitation should help you understand
Our suggested questions are which tests might be offered, how allocation works, what further investigations could follow and how results will be explained. Ask about the time commitment and the support available when deciding whether to participate.
Better representation is important to the usefulness of the eventual evidence. It should be pursued through clear information and trust, not pressure on an individual to take part.
For a reader worried about prostate symptoms or personal risk now, a trial invitation should not be the only route to a conversation. Discuss those concerns with your healthcare professional. The research announcement is about building future evidence, rather than guaranteeing a test or treatment today.
Related UK reporting
Prostate Progress: understanding the NHS research invitation
Known facts
- Additional funding announced in June 2026 aims to widen Black men’s participation. Expansion is staged, with invitations rather than self-referral.
